Publications by authors named "Leif Erhardt"

Claim this Profile
C
Cheyne-Stokes respiration is not related to quality of life or sleepiness in heart failure.
Bengt Midgren, Lena Mared, Karl Anders Franklin, Søren Berg, Leif Erhardt

Clin Respir J· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cigarette smoking: an undertreated risk factor for cardiovascular disease.
Leif Erhardt

Atherosclerosis· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiologists' awareness and perceptions of guidelines for chronic heart failure. The ADDress your Heart survey.
Leif Erhardt, Michel Komajda, F D Richard Hobbs, Jordi Soler-Soler

Eur J Heart Fail· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The From The Heart study: a global survey of patient understanding of cholesterol management and cardiovascular risk, and physician-patient communication.
F D Richard Hobbs, Leif R Erhardt, Catherine Rycroft,

Curr Med Res Opin· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipid management in cardiovascular disease prevention guidelines: strategies and tactics for implementation.
Leif R Erhardt, Lawrence A Leiter, F D Richard Hobbs

Atherosclerosis· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale for multiple risk intervention: the need to move from theory to practice.
Leif R Erhardt

Vasc Health Risk Manag· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive cardiovascular risk management--what does it mean in practice?
Leif Erhardt, Robert Moller, Juan García Puig

Vasc Health Risk Manag· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of carvedilol and metoprolol on the mode of death in patients with heart failure.
Willem J Remme, John G Cleland, Leif Erhardt, Phillip Spark, Christian Torp-Pedersen

Eur J Heart Fail· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rationale, design, and methods for the risk evaluation and communication health outcomes and utilization trial (REACH OUT).
Joshua S Benner, Spencer B Cherry, Leif Erhardt, Michèle Fernandes, Martina Flammer

Contemp Clin Trials· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatments with losartan or enalapril are equally sensitive to deterioration in renal function from cyclooxygenase inhibition.
Tord Juhlin, Leif R Erhardt, Helene Ottosson, Bo A G Jönsson, Peter Höglund

Eur J Heart Fail· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Knowing your risk factors for coronary heart disease improves adherence to advice on lifestyle changes and medication.
Carin Alm-Roijer, Bengt Fridlund, Martin Stagmo, Leif Erhardt

J Cardiovasc Nurs· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of the effects of carvedilol and metoprolol on well-being, morbidity, and mortality (the "patient journey") in patients with heart failure: a report from the Carvedilol Or Metoprolol European Trial (COMET).
John G F Cleland, Andrew Charlesworth, Jacobus Lubsen, Karl Swedberg, Willem J Remme, Leif Erhardt

J Am Coll Cardiol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The evolution of European guidelines: changing the management of cholesterol levels.
Leif R Erhardt, A Gotto

Atherosclerosis· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Barriers to effective implementation of guideline recommendations.
Leif R Erhardt

Am J Med· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypertensive smokers have a worse cardiovascular risk profile than non-smokers in spite of treatment--a national study in Sweden.
Gunilla Journath, Peter M Nilsson, Ulla Petersson, Bo-Anders Paradis, Holger Theobald, Leif Erhardt

Blood Press· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice.
John McMurray, Alain Cohen-Solal, Rainer Dietz, Eric Eichhorn, Leif Erhardt

Eur J Heart Fail· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An emerging role for calcium sensitisation in the treatment of heart failure.
Leif Erhardt

Expert Opin Investig Drugs· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Better knowledge improves adherence to lifestyle changes and medication in patients with coronary heart disease.
Carin Alm-Roijer, Martin Stagmo, Giggi Udén, Leif Erhardt

Eur J Cardiovasc Nurs· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cheyne-Stokes respiration in patients hospitalised for heart failure.
Lena Mared, Charles Cline, Leif Erhardt, Søren Berg, Bengt Midgren

Respir Res· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is magnesium deficit in lymphocytes a part of the mitral valve prolapse syndrome?
Mariusz Kitliński, Marek Stepniewski, Jadwiga Nessler, Ewa Konduracka, Katarzyna Solarska, Leif Erhardt

Magnes Res· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A description of the clinical characteristics at baseline of patients recruited into the Carvedilol or Metoprolol European Trial (COMET).
John G F Cleland, Kevin Goode, Leif Erhardt, Willem J Remme, Andrew Charlesworth

Cardiovasc Drugs Ther· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of fixed low-dose warfarin added to aspirin in the long term after acute myocardial infarction; the LoWASA Study.
Johan Herlitz, Johan Holm, Magnus Peterson, Björn W Karlson, Maria Haglid Evander, Leif Erhardt

Eur Heart J· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Swedish National Programme for Quality Control of Secondary Prevention of Coronary Artery Disease--results after one year.
Martin Stagmo, Bo Israelsson, Hans Brandström, Bo Hedbäck, Hans Lingfors, Leif Erhardt

Eur J Cardiovasc Prev Rehabil· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of elevated creatine kinase MB after coronary bypass surgery and after an acute coronary syndrome: results from the GUARDIAN trial.
Jeffrey A Gavard, Bernard R Chaitman, Shunta Sakai, Karen Stocke, Nicolas Danchin, Leif Erhardt

J Thorac Cardiovasc Surg· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is calcium sensitization the best strategy to improve myocardial contractility in acute heart failure?
Leif R Erhardt

Ital Heart J· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis